Global Pharmaceutical Excipients Market: Industry Analysis, Trends, Market Size and Forecasts up to 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The “Pharmaceutical Excipients Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering.
The report on global pharmaceutical excipients market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global pharmaceutical excipients market to grow with a CAGR of 5.5% over the forecast period of 2018-2024. The study on pharmaceutical excipients market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The report on pharmaceutical excipients market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pharmaceutical excipients market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
The top 5 most relevant categories of excipient are coatings, acids, solvents, binders and emulsifiers. Coating and binders are commonly used in oral solid dosage form such as tablets and capsules, while solvents, emulsifiers and buffers are prevalent in topical products.
Thus increasing demand for functional excipients coupled with growth in pharmaceutical industry to drive the pharmaceutical excipients market. However stringent government regulations and lengthy FDA process approvals are likely to affect the growth of the pharmaceutical excipients market. Continuous research and development activities in developing new excipients functionalities and enhancing existing excipient functionalities will further help to create future growth opportunities.
Europe held the largest market share of the pharmaceutical excipients market in 2017, followed by North America. Europe accounted for highest market share owing to the presence of well-established pharmaceutical companies such as Novartis and Roche, whose large production capacities lead to high quantity of excipient consumption.
Asia pacific is expected to grow at the highest CAGR during the forecast period on account of improving healthcare infrastructure coupled with increase in the penetration of health care insurance in Asia pacific countries.
Companies MentionedBASF Ashland Global Specialty Chemicals Inc. The Dow Chemical Company, Roquette Evonik Industries Archer Daniels Midland Associated British Foods Archer Daniels Midland Company Lubrizol Chemical Company Kerry Group
For more information about this report visit https://www.researchandmarkets.com/research/j7342l/global?w=4 4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005432/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Pharmaceutical Intermediates
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/13/2018 02:26 PM/DISC: 07/13/2018 02:26 PM